Myriad Genetics Inc
XHAM:MYD
Myriad Genetics Inc
XHAM:MYD
Price:
3.256
EUR
0.65%
Market Closed
Market Cap:
€292.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Myriad Genetics Inc
XHAM:MYD
|
US |
|
Arqit Quantum Inc
NASDAQ:ARQQ
|
UK |
|
SEMrush Holdings Inc
F:628
|
US |
|
M
|
Myriad Genetics Inc
SWB:MYD
|
US |
|
Norcros PLC
F:3N1N
|
UK |
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
US |
Wall St Price Targets
MYD Price Targets Summary
Myriad Genetics Inc
Myriad Genetics Inc
Wall Street analysts forecast MYD stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MYD is 5.395 EUR with a low forecast of 3.435 EUR and a high forecast of 8.926 EUR.
Lowest Forecast
Price Target
3.435
EUR
5% Upside
Average Forecast
Price Target
5.395
EUR
66% Upside
Highest Forecast
Price Target
8.926
EUR
174% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYD's stock price target?
Price Target
5.395
EUR
5.395
EUR
According to Wall Street analysts, the average 1-year price target for MYD is 5.395 EUR with a low forecast of 3.435 EUR and a high forecast of 8.926 EUR.
What is the Revenue forecast for Myriad Genetics Inc?
Projected CAGR
6%
6%
Over the last 4 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is 6%.
